[Federal Register Volume 89, Number 208 (Monday, October 28, 2024)]
[Notices]
[Page 85550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24972]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via web conference on December 3, 2024, from 
10 a.m. EST to 2:30 p.m. EST.
    The board will meet in open session December 3, 2024, from 10 a.m. 
EST to 2:30 p.m. EST to hear updates from the Department of 
Transportation (DOT), the Department of Defense (DoD) and the Nuclear 
Regulatory Commission (NRC), and updates from HHS on the Federal 
Workplace Drug Testing Program and Mandatory Guidelines. Additionally, 
the board will hear presentations regarding a collaboration between the 
Department of Defense and the Division of Workplace Programs as well as 
data presented for consideration regarding evaluation of the cutoff for 
an invalid pH result in urine.
    Data provided by HHS-certified laboratories indicates that invalid 
urine pH results cycle with the seasonal temperature fluctuations. Data 
will be presented to facilitate and inform decisions regarding a 
possible adjustment in the cutoff for urine pH to reduce this cyclical 
effect while continuing to identify potential tampering of specimens.
    Meeting registration information can be completed at https://snacregister.samhsa.gov/. Web conference and call information will be 
sent after completing registration. Meeting information and a roster of 
DTAB members may be obtained by accessing the SAMHSA Advisory 
Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings, or by contacting the Designated Federal Officer, Lisa Davis.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: December 3, 2024, from 10:00am EST to 2:30pm EST: 
Open.
    Place: Virtual.
    To Submit Comments: Requests to make public comment during the 
public comment period of the December DTAB meeting must be made in 
writing at least 7 days prior to the meeting to the following email: 
<a href="/cdn-cgi/l/email-protection#d89c9e8f8898abb9b5b0abb9f6b0b0abf6bfb7ae"><span class="__cf_email__" data-cfemail="3d797b6a6d7d4e5c50554e5c1355554e135a524b">[email protected]</span></a>.
    Contact: Lisa S. Davis, M.S, Social Science Analyst, Center for 
Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland, 
20857, Telephone: (240) 276-1440, Email: <a href="/cdn-cgi/l/email-protection#511d3822307f15302738221122303c3922307f3939227f363e27"><span class="__cf_email__" data-cfemail="5c10352f3d72183d2a352f1c2f3d31342f3d7234342f723b332a">[email protected]</span></a>.

Anastasia Flanagan,
Public Health Advisor, Division of Workplace Programs.
[FR Doc. 2024-24972 Filed 10-25-24; 8:45 am]
BILLING CODE 4162-20-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>